Abstract

PurposeTo assess radiation exposure in men undergoing prostate artery embolization (PAE) for the treatment for symptomatic, benign prostatic hyperplasia depending on growing experience of interventional radiologists over a 4-year period.MethodsA total of 250 consecutive patients underwent PAE at a single center. Data on radiation exposure [dose area product (DAP), effective dose (ED), entrance skin dose (ESD), and fluoroscopy time (FT)] were retrospectively evaluated. Primary outcomes of interest were patient radiation exposure in five consecutive groups of 50 patients each and Pearson correlation with the number of patients treated.ResultsMedian DAP, ED, and ESD during prostate artery embolization were significantly higher in the first compared to the second 50 patients (56 298 µGym2 vs. 24 709 µGym2, p < 0.001, 146.4 mSv vs. 64.2 mSv, p < 0.001, and 5.1 Gy vs. 2.4 Gy, p < 0.001, respectively). The following consecutive groups did not differ significantly from the respective preceding group in terms of DAP, ED, and ESD. Number of digital subtraction angiography series, FT, and procedure time decreased with increasing operator experience (Pearson’s r = − 0.240, p < 0.001, r = − 0.269, p < 0.001, and r = − 0.504, p < 0.001, respectively). Bilateral prostate artery embolization was associated with less ESD and shorter FT than unilateral embolization (median 2.5 vs. 3.5 Gy, p = 0.02, and 26 min vs. 42 min, p < 0.001, respectively).ConclusionExposure to radiation in men who underwent PAE decreased with growing operator experience and decreasing complexity of procedures.

Highlights

  • Number of men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) increased over recent years [1]

  • Median international prostate symptom score (IPSS) was 23 (IQR: 9), and median quality of life according to IPSS question 8 was 5 (IQR: 1)

  • Body mass index (BMI) and severity of LUTS were well balanced across consecutive groups (Table 2)

Read more

Summary

Introduction

Number of men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) increased over recent years [1]. Prostate arteries (PA) are small vessels with a high variability of origins [7, 8]. Identification of PA origins, duplicated PAs, contralateral perfusion of the prostate gland, and anastomoses with vesical, rectal, or penile arteries is challenging and time-consuming [7,8,9]. Procedure time and number of digital subtraction angiography (DSA) acquisitions, are known to increase patient’s radiation exposure. Wang et al [7] identified cone beam computed tomography (CBCT) angiography as a useful complement to fluoroscopy and DSA.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call